Holding a Ph.D. in Obstetrics and Gynecology from the University of Melbourne in Australia, Alexander Stojanoff currently applies himself as Chief Executive Officer of United Fertility Centers of America (UFCoA). Prior to joining UFCoA in 2008, Dr. Stojanoff employed his extensive medical knowledge and decades of clinical experience in a variety of research, patient care, and academic capacities. Dr. Stojanoff’s past roles include IVF (in vitro fertilization) Scientist at the University of Melbourne’s Royal Women’s Hospital; Scientific Director for Alvarado Hospital’s IVF clinic in San Diego, California; Lab Director for the Nevada Institute for Fertility and Genetics, and Assistant Professor at the University of Nevada School of Medicine, to name a few.
In his role at the helm of United Fertility Centers of America, Alexander Stojanoff utilizes his background in reproductive medicine to establish a solid and profitable foundation for the in vitro fertilization laboratories and clinics operating under the auspices of UFCoA. One of the company’s most recent acquisitions, the Muasher Center for Fertility and IVF (MCFIVF), offers patients a wide scope of infertility treatment options, all of which are administered by a highly trained staff of skilled and compassionate physicians. Overseen by board-certified reproductive endocrinologists Dr. Suheil J. Muasher and Dr. Nancy Durso, MCFIVF manages a leading-edge donor egg program, providing infertile couples with additional family planning tools when other methodologies prove ineffective.
Although many patients who come to the Muasher Center for Fertility and IVF respond positively to oral medications, hormone injections, intrauterine insemination (IUI), or traditional in vitro fertilization, some women remain unable to produce viable eggs that are healthy enough to support a pregnancy. In cases like this, Dr. Muasher and Dr. Durso often recommend donor eggs as an alternative to take into serious consideration. Likewise, women who demonstrate an increased risk for conceiving a child with birth defects stand to benefit markedly from MCFIVF’s innovative donor egg program.
In his role at the helm of United Fertility Centers of America, Alexander Stojanoff utilizes his background in reproductive medicine to establish a solid and profitable foundation for the in vitro fertilization laboratories and clinics operating under the auspices of UFCoA. One of the company’s most recent acquisitions, the Muasher Center for Fertility and IVF (MCFIVF), offers patients a wide scope of infertility treatment options, all of which are administered by a highly trained staff of skilled and compassionate physicians. Overseen by board-certified reproductive endocrinologists Dr. Suheil J. Muasher and Dr. Nancy Durso, MCFIVF manages a leading-edge donor egg program, providing infertile couples with additional family planning tools when other methodologies prove ineffective.
Although many patients who come to the Muasher Center for Fertility and IVF respond positively to oral medications, hormone injections, intrauterine insemination (IUI), or traditional in vitro fertilization, some women remain unable to produce viable eggs that are healthy enough to support a pregnancy. In cases like this, Dr. Muasher and Dr. Durso often recommend donor eggs as an alternative to take into serious consideration. Likewise, women who demonstrate an increased risk for conceiving a child with birth defects stand to benefit markedly from MCFIVF’s innovative donor egg program.